File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures

TitleNonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures
Authors
Keywordsdisease surveillance
human
infection control
influenza A (H1N1)
nonhuman
Issue Date2020
PublisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm
Citation
Emerging Infectious Diseases, 2020, v. 26 n. 5, p. 961-966 How to Cite?
AbstractInternational travel–related nonpharmaceutical interventions (NPIs), which can include traveler screening, travel restrictions, and border closures, often are included in national influenza pandemic preparedness plans. We performed systematic reviews to identify evidence for their effectiveness. We found 15 studies in total. Some studies reported that NPIs could delay the introduction of influenza virus. However, no available evidence indicated that screening of inbound travelers would have a substantial effect on preventing spread of pandemic influenza, and no studies examining exit screening were found. Some studies reported that travel restrictions could delay the start of local transmission and slow international spread, and 1 study indicated that small Pacific islands were able to prevent importation of pandemic influenza during 1918–19 through complete border closure. This limited evidence base indicates that international travel-related NPIs would have limited effectiveness in controlling pandemic influenza and that these measures require considerable resources to implement.
Persistent Identifierhttp://hdl.handle.net/10722/283684
ISSN
2021 Impact Factor: 16.126
2020 SCImago Journal Rankings: 2.540
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRyu, S-
dc.contributor.authorGao, H-
dc.contributor.authorWong, JY-
dc.contributor.authorShiu, EYC-
dc.contributor.authorXiao, J-
dc.contributor.authorFong, MW-
dc.contributor.authorCowling, BJ-
dc.date.accessioned2020-07-03T08:22:40Z-
dc.date.available2020-07-03T08:22:40Z-
dc.date.issued2020-
dc.identifier.citationEmerging Infectious Diseases, 2020, v. 26 n. 5, p. 961-966-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/10722/283684-
dc.description.abstractInternational travel–related nonpharmaceutical interventions (NPIs), which can include traveler screening, travel restrictions, and border closures, often are included in national influenza pandemic preparedness plans. We performed systematic reviews to identify evidence for their effectiveness. We found 15 studies in total. Some studies reported that NPIs could delay the introduction of influenza virus. However, no available evidence indicated that screening of inbound travelers would have a substantial effect on preventing spread of pandemic influenza, and no studies examining exit screening were found. Some studies reported that travel restrictions could delay the start of local transmission and slow international spread, and 1 study indicated that small Pacific islands were able to prevent importation of pandemic influenza during 1918–19 through complete border closure. This limited evidence base indicates that international travel-related NPIs would have limited effectiveness in controlling pandemic influenza and that these measures require considerable resources to implement.-
dc.languageeng-
dc.publisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm-
dc.relation.ispartofEmerging Infectious Diseases-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectdisease surveillance-
dc.subjecthuman-
dc.subjectinfection control-
dc.subjectinfluenza A (H1N1)-
dc.subjectnonhuman-
dc.titleNonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures-
dc.typeArticle-
dc.identifier.emailWong, JY: wongytj@hku.hk-
dc.identifier.emailShiu, EYC: eunshiu@connect.hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.authorityCowling, BJ=rp01326-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3201/eid2605.190993-
dc.identifier.pmid32027587-
dc.identifier.pmcidPMC7181936-
dc.identifier.scopuseid_2-s2.0-85083620667-
dc.identifier.hkuros310744-
dc.identifier.volume26-
dc.identifier.issue5-
dc.identifier.spage961-
dc.identifier.epage966-
dc.identifier.isiWOS:000529306800016-
dc.publisher.placeUnited States-
dc.identifier.issnl1080-6040-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats